Gourlay G K, Plummer J L, Cherry D A, Purser T
J Pain Symptom Manage. 1991 Oct;6(7):431-6. doi: 10.1016/0885-3924(91)90042-3.
The reproducibility in bioavailability of orally administered morphine (as a solution) under fed and fasted conditions was studied in 5 patients with chronic pain on three occasions over 1 yr (0, 6, and 12 mo). During each study period (i.e.. 0, 6, and 12 mo), patients received the 50 mg oral dose both in the fasted state (10 hr since food) and immediately after a high fat content breakfast, in randomly determined sequence. Frequent blood samples were collected for 10 hr after the dose. There was no significant difference in the maximum blood morphine concentration (Cmax) or the time to Cmax among the three study periods or between the fed and fasted states. Bioavailability, as assessed by log(AUC), was significantly greater in the fed compared to the fasted state (P less than .01) but did not differ over the three study periods (Two-factor analysis of variance). Intrapatient variability contributed 32% and 54% to total variation in log(AUC) under fed and fasted conditions, respectively.
在1年(0、6和12个月)内分三次对5名慢性疼痛患者进行研究,观察口服吗啡(溶液剂型)在进食和空腹条件下生物利用度的重现性。在每个研究阶段(即0、6和12个月),患者在空腹状态(进食后10小时)和高脂早餐后立即按随机确定的顺序接受50mg口服剂量。给药后10小时频繁采集血样。三个研究阶段之间或进食与空腹状态之间,最大血药吗啡浓度(Cmax)或达峰时间均无显著差异。通过对数曲线下面积(log[AUC])评估,进食状态下的生物利用度显著高于空腹状态(P<0.01),但在三个研究阶段中无差异(双因素方差分析)。在进食和空腹条件下,患者自身变异性分别占log[AUC]总变异的32%和54%。